FREDERICK, Md.--(BUSINESS WIRE)--BioFactura, Inc. today announced a contract awarded by the Biomedical Advanced Research and Development Authority (BARDA) valued at up to $67.4 million for the ...
TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox, was just approved by the U.S. Food and Drug Administration to SIGA Technologies Inc. The development of TPOXX was in ...
TNX-801 is Based on the Sequence of a Natural Isolate of Horsepox and is Believed Closer in Structure to Edward Jenner’s 1798 Vaccine than Modern Vaccinia Virus Vaccines Against Smallpox As presented ...
An ad hoc committee of the National Academies of Sciences, Engineering, and Medicine will conduct a study to examine lessons learned from the recent Coronavirus Disease 2019 (COVID-19) pandemic and ...
The US Food and Drug Administration (FDA) on Friday finalized guidance on developing drugs to treat smallpox, clarifying aspects of a revised draft guidance released last year. While smallpox was ...
FREDERICK, Md.--(BUSINESS WIRE)--BioFactura, Inc. today announced a contract awarded by the Biomedical Advanced Research and Development Authority (BARDA) valued at up to $67.4 million for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results